GERANIUM OIL, EGYPT

Hazard statements (CLP)

H315, H317, H319, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Classification of the substance or mixture Skin Irritant- Category 2 - H315 Eye Irritant - Category 2 - H319 Skin sensitizer - Category 1 B - H317 Hazardous to the aquatic environment, long-term (chronic) - Category 2 - H411

2.2 Label elements

¢

Signal word

Warning

Hazard statements

H315 -Causes skin irritation. H317 -May cause an allergic skin reaction. H319 -Causes serious eye irritation. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P261 -Avoid breathing dust/fume/gas/mist/vapours/spray. P280 -Wear protective glovesiprotective clothing/eye protection/face protection. P302+P352+P333+P313 -IF ON SKIN Wash with plenty of soap and water. If skin irritation or rash occurs Get medical advice/attention P305+P351+P338+P337+P313 - IF IN EVES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention.

Supplemental label elements

Contains CITRONELLOL, GERANIOL, LINALOOL, ALPHA-PINENE, LIMON ENE, BETA-PIN ENE, MENTHONE, ISOMENTHONE, GERANYL FORMATE, CITRONELLYL BUTYRATE, CITRONELLYL TIGLATE, CITRONELLYL FORMATE, BETA-CARYOPHYLLENE, CITRONELLYL PROPIONATE, CITRAL. May produce an allergic reaction.

2.3 Other hazards

Product not containing any component that meets the criteria for PBT o vPvB according to Regulation (EC) 1907 /2006, Annex XIII. Product not containing any component identified as having endocrine disrupting properties according to Regulation (EU) 2017 /2100. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS 3.1. Substances Chemical name GERANIUM CAS number: 90082-51-2 EC number: 290-140-0 Hazardous constituents: CAS No. Classification according Specific Concentration Chemical Name 0/o(w/w) EC No. to Regulation 1272/2008 Index No. Limit, M-factor, ATE, SVHC Skin lrrit. 2 - H315 CITRONELLOL 106-22-9 ATE (oral): 3450 mg/kg, ATE 2'.25; <50 203-375-0 Eye lrrit. 2 - H319 (dermal): 2650 mg/kg Skin Sens. 1B- H317 106-24-1 Skin lrrit. 2 - H315 GERANIOL 2'.10; <25 203-377-1 Eye Dam. 1 - H318 ATE (oral): 3600 mg/kg 603-241-00-5(ATP15) Skin Sens. 1 -H317 CITRONELLYL FORMATE 2'.1;<10 105-85-1 Skin lrrit. 2 - H315 203-338-9 Skin Sens. 1 B- H317 Acute Tox. 4 (inhalation) -H332 ISOMENTHONE 2'.1;<10 491-07-6 Skin lrrit. 2 - H315 ATE (oral): 2219 mg/kg, AT E 207-727-4 Skin Sens. 18- H317 (inhalation, dust/mist): 1,5 mg/L 78-70-6 Skin lrrit. 2 - H315 LINALOOL 2'.1;<10 201-134-4 Eye lrrit. 2 - H319 ATE (oral): 2790 mg/kg Skin Sens. 1 B- H317 Skin Sens. 18- H317 GERANYL FORMATE 2'.1; <10 105-86-2 203-339-4 Aquatic Acute 1 - H400 Aquatic Chronic 2 - GERANYL BUTYRATE 106-29-6 H411 2'.1;<10 203-381-3 Aquatic Chronic 2 - H411 ATE (dermal): 5000 mg/kg 1074-95-9 Acute Tox. 4 (inhalation) - H332 ATE (oral): 2219 mg/kg, ATE MENTHONE 2:1; <10 214-049-2 Skin lrrit. 2 -H315 (inhalation, dust/mist): 1,5 mg/L Skin Sens. 1 B - H317 BETA-CARYOPHYLLEN E 2'.1;<10 87-4£..-5 Skin Sens. 201-746-1 1B-H317 Asp. Tox. 16409-43-1 1 Skin - H304 lrrit. 2 -H315 ROSE OXIDE 2:1; <10 240-457-5 Eye lrrit. 2 - H319 ATE (oral): 4300 mg/kg Repr. 2 - H361 5392-40-5 Skin lrrit. 2 -H315 CITRAL 2:1; <10 226-394-6 Eye lrrit. 2 - H319 605-019-00-3(ATP 19) Skin Sens. 1 - H317 Flam. Liq. 3 - H226 Acute Tox. 4 (oral)- H302 Skin lrrit. 2 - H315 -· ALPHA-PIN ENE ;::::0.1;<1 80-56-8 Skin Sens. 1B - H317 Asp. ATE (oral): 500 mg/kg , 201-291-9 Tox. 1 -H304 Aquatic Acute 1 -H400 Aquatic ,. Chronic 1 - H410 141-16-2 Skin Sens. 18- H317 CITRONELLYL BUTYRATE .. 2:0.1;<1 - Aquatic Acute 1 -H400 J -• _,- r 205-463-4 . Aquatic Chronic 1 - H410 I, ' l 24717-85-9 Skin Sens. 1B - H317 CITRONEL LYL TIGLATE ;::::0.1;<1 246-426-2 Aquatic Acute 1 -H400 M (acute) 10, M (chronic) 10 Aquatic Chronic 1 - H410 141-14-0 .. Skin Sens. 18- H317 ' CITRONELLYL PROPIONATE ;::::0.1;<1 205-461-3 ,Aquatic Chronic 2 - H411 \ . Flam. Liq. 3 - H226 \ - y 138-86-3 Skin lrrit. 2 -H315 Skin ' LIMON ENE 2:0.1;<1 205-341-0 Sens. 1B- H317 Asp. I 601-029-00-7(ATP 24) Tox. 1 -H304 Aqua tic Acute 1 - H400 Aquatic ' J f';· Chronic 3 - H412 - ... .. . I - ... - ... . .. ... . .. ... Flam. Liq. 3 - H226 Skin lrrit. 2 - H315 :::::0.1;<1 127-91-3 Skin Sens. 1B - H317 BETA-PIN ENE 204-872-5 Asp. Tox. 1 - H304 Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410 See the full text of the hazard statements in section 16.

2.1 Classification of the substance or mixture

Skin Irritant- Category 2 - H315 Eye Irritant - Category 2 - H319 Skin sensitizer - Category 1 B - H317 Hazardous to the aquatic environment, long-term (chronic) - Category 2 - H411 2.2. Label Elements ¢ Hazard pictograms: Signal Word: Warning Hazard statements: H315 -Causes skin irritation. H317 -May cause an allergic skin reaction. H319 -Causes serious eye irritation. H411 - Toxic to aquatic life with long lasting effects. Precautionary statements: P261 -Avoid breathing dust/fume/gas/mist/vapours/spray. P280 -Wear protective glovesiprotective clothing/eye protection/face protection. P302+P352+P333+P313 -IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice/attention. P305+P351+P338+P337+P313 - IF IN EVES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. Suplemental Hazard Information: Contains CITRONELLOL, GERANIOL, LINALOOL, ALPHA-PINENE, LIMON ENE, BETA-PIN ENE, MENTHONE, ISOMENTHONE, GERANYL FORMATE, CITRONELLYL BUTYRATE, CITRONELLYL TIGLATE, CITRONELLYL FORMATE, BETA-CARYOPHYLLENE, CITRONELLYL PROPIONATE, CITRAL. May produce an allergic reaction. 2.3. Other hazards Product not containing any component that meets the criteria for PBT o vPvB according to Regulation (EC) 1907 /2006, Annex XIII. Product not containing any component identified as having endocrine disrupting properties according to Regulation (EU) 2017 /2100. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS 3.1. Substances Chemical name : GERANIUM CAS number: 90082-51-2 EC number: 290-140-0 Hazardous constituents: CAS No. Classification according Specific Concentration Chemical Name 0/o(w/w) EC No. to Regulation 1272/2008 Index No. Limit, M-factor, ATE, SVHC Skin lrrit. 2 - H315 CITRONELLOL 106-22-9 ATE (oral): 3450 mg/kg, ATE 2'.25; <50 203-375-0 Eye lrrit. 2 - H319 (dermal): 2650 mg/kg Skin Sens. 1B- H317 106-24-1 Skin lrrit. 2 - H315 GERANIOL 2'.10; <25 203-377-1 Eye Dam. 1 - H318 ATE (oral): 3600 mg/kg 603-241-00-5(ATP15) Skin Sens. 1 -H317 CITRONELLYL FORMATE 2'.1;<10 105-85-1 Skin lrrit. 2 - H315 203-338-9 Skin Sens. 1 B- H317 Acute Tox. 4 (inhalation) -H332 ISOMENTHONE 2'.1;<10 491-07-6 Skin lrrit. 2 - H315 ATE (oral): 2219 mg/kg, AT E 207-727-4 Skin Sens. 18- H317 (inhalation, dust/mist): 1,5 mg/L 78-70-6 Skin lrrit. 2 - H315 LINALOOL 2'.1;<10 201-134-4 Eye lrrit. 2 - H319 ATE (oral): 2790 mg/kg Skin Sens. 1 B- H317 Skin Sens. 18- H317 GERANYL FORMATE 2'.1; <10 105-86-2 203-339-4 Aquatic Acute 1 - H400 Aquatic Chronic 2 - GERANYL BUTYRATE 106-29-6 H411 2'.1;<10 203-381-3 Aquatic Chronic 2 - H411 ATE (dermal): 5000 mg/kg 1074-95-9 Acute Tox. 4 (inhalation) - H332 ATE (oral): 2219 mg/kg, ATE MENTHONE 2:1; <10 214-049-2 Skin lrrit. 2 -H315 (inhalation, dust/mist): 1,5 mg/L Skin Sens. 1 B - H317 BETA-CARYOPHYLLEN E 2'.1;<10 87-4£..-5 Skin Sens. 201-746-1 1B-H317 Asp. Tox. 16409-43-1 1 Skin - H304 lrrit. 2 -H315 ROSE OXIDE 2:1; <10 240-457-5 Eye lrrit. 2 - H319 ATE (oral): 4300 mg/kg Repr. 2 - H361 5392-40-5 Skin lrrit. 2 -H315 CITRAL 2:1; <10 226-394-6 Eye lrrit. 2 - H319 605-019-00-3(ATP 19) Skin Sens. 1 - H317 Flam. Liq. 3 - H226 Acute Tox. 4 (oral)- H302 Skin lrrit. 2 - H315 -· ALPHA-PIN ENE ;::::0.1;<1 80-56-8 Skin Sens. 1B - H317 Asp. ATE (oral): 500 mg/kg , 201-291-9 Tox. 1 -H304 Aquatic Acute 1 -H400 Aquatic ,. Chronic 1 - H410 141-16-2 Skin Sens. 18- H317 CITRONELLYL BUTYRATE .. 2:0.1;<1 - Aquatic Acute 1 -H400 J -• _,- r 205-463-4 . Aquatic Chronic 1 - H410 I, ' l 24717-85-9 Skin Sens. 1B - H317 CITRONEL LYL TIGLATE ;::::0.1;<1 246-426-2 Aquatic Acute 1 -H400 M (acute): 10, M (chronic): 10 Aquatic Chronic 1 - H410 141-14-0 .. Skin Sens. 18- H317 ' CITRONELLYL PROPIONATE ;::::0.1;<1 205-461-3 ,Aquatic Chronic 2 - H411 \ . Flam. Liq. 3 - H226 \ - y 138-86-3 Skin lrrit. 2 -H315 Skin ' LIMON ENE 2:0.1;<1 205-341-0 Sens. 1B- H317 Asp. I 601-029-00-7(ATP 24) Tox. 1 -H304 Aqua tic Acute 1 - H400 Aquatic ' J f';· Chronic 3 - H412 - ... .. . I - ... - ... . .. ... . .. ... Flam. Liq. 3 - H226 Skin lrrit. 2 - H315 :::::0.1;<1 127-91-3 Skin Sens. 1B - H317 BETA-PIN ENE 204-872-5 Asp. Tox. 1 - H304 Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410 See the full text of the hazard statements in section 16. 3.2. Mixtures Not applicable. SECTION 4. FIRST-AID MEASURES 4.1. Description of necessary first aid measures Ingestion: Rinse mouth with water. Obtain medical advice. Keep at rest. Do not induce vomiting. Eye contact: In case of contact with eyes, rinse immediately with plenty of water for at least 15 minutes and seek medical advice. Inhalation: Remove person to fresh air and keep at rest. ( Seek immediate medical advice. Skin contact: Take off immediately all contaminated clothing. Thoroughly wash affected skin with soap and water. Seek medical attention if symptoms persist. 4.2. Most important symptoms and effects, both acute and delayed No information available. 4.3. Indication of any immediate medical attention and special treatment needed No information available. 5.1. Extinguishing Media Water spray, carbon dioxide, dry chemical powder or appropriate foam. For safety reasons do not use full water jet. 5.2. Special hazards arising from the substance or mixture Known or Anticipated Hazardous Products of Combustion: Emits toxic fumes under fire conditions. 5.3. Advice for firefighters High temperatures can lead to high pressures inside closed containers. Avoid inhalation of vapors that are created. Use appropriate respiratory protection. Do not allow spillage of fire to be poured into drains or watercourses. 1 Wear self-contained breathing apparatus and protective clothing. SECTION 6. ACCIDENTAL RELEASE MEASURES 6.1. Personal precautions, protective equipment and emergency procedures Evacuate surronding areas. Ensure adequate ventilation. Keep unnecessary and unprotected personnel from entering. I< Do not breathe vapor/spray. Avoid contact with skin and eyes. Information regarding personal protective measures: see section 8. 6.2. Environmental precautions To avoid possible contamination of the environment, do not discharge into any drains, surface waters or groundwaters. 6.3. Methods and materials for containment and cleaning up Cover with an inert, inorganic, non-combustible absorbent material (e.g. dry-lime, sand, soda ash). Place in covered containers using non-sparking tools and transport outdoors. Avoid open flames or sources of ignition (e.g. pilot lights on gas hot water heater). Ventilate area and wash spill site after material pickup is complete. 6.4. Reference to other sections Information regarding exposure controls, personal protection and disposal cgnsiderations can be found in sections 8 and 13. SECTION 7. HANDLING AND STORAGE 7.1. Precautions for safe handling Do not store or handle this material near food or drinking water. Do not smoke. Avoid contact with the eyes, skin and clothing. Wear protective clothing and use glasses. Observe the rules of safety and hygiene at work. Keep in the original container or an alternative maoe from a compatible material. 7.2. Conditions for safe storage, including any incompatibilities Store in tightly closed and preferably full containers in a cool, dry and ventilated area, protected from light. Keep away from sources of ignition (e.g. hot surfaces, sparks, flame and static discharges). Keep away from incompatible materials (see section 10). 7.3. Specific end use(s) No information available. SECTION 8. EXPOSURE CONTROLS AND PERS ONAL PROTECTION 8.1. Control parameters Components with occupational exposure limits: Chemical Name CAS No. Norm. 8 hr. 15min. ppm mg/m' ppm mg/m3 ES (Espana) VLA-ED 5 VLA-EC CITRAL 5392-40-5 PL (Polska) NDS 27 NDSCh 54 ALPHA-PIN ENE 80-56-8 ES (Espana) VLA-ED 20 113 VLA-EC BETA-PINENE 127-91-3 ES (Espana) VLA-ED 20 113 VLA-EC 1 Possibility of significant uptake though the skin. 8.2. Exposure controls Appropriate engineering controls: Measures should be taken to prevent materials from being splashed into the body. Provide adequate ventilation, according to the conditions of use. Use a mechanical exhaust if required. Eye;Face protection: Chemical safety goggles are recommended. Wash contaminated goggles before reuse. Hand Protection: Chemical-resistant gloves are recommended. Wash contaminated gloves before reuse. Body protection: Personal protective equipment for the body should be selected based on the task being performed and the risks involved. Respiratory Protection: In case of insufficient ventilation, use suitable respiratory equipment. Environmental exposure controls: Emissions from ventilation or process eouipment should be checked to ensure they comply with environmental protection legislation. In some cases, filters or engineering modifications to the process equipment will be necessary to reduce emissions to acceptable levels. 9.1. Information on basic physical and chemical properties Physical sate: Liquid Colour: Conforms to standard Odour: Conforms to standard Melting point/freezing point: Not determined Boiling point or initial boiling point and range (0C): Not Flammability: determined Lower and upper explosion limit: Not Flash point: determined 90 °C Not Auto-ignition temperature: determined Not determined Decomposition temperature: Not pH: determined Not Kinematic viscosity: determined Solubility: Not 1:4 \N determined ETHANOL 70°/SOLUBLE IN ETHANOL Partition coefficient n-octanol/water (log value): Not determined Vapour pressure: Not determined Density and/or relative density: 0,884-0,901 g/ml (20°() / 0,884-0,901 Relative vapour drnsity: (20°C) Not determined Particle characteristics: Not determined 9.2. Other information 9.2.1. Information with regard to phyical hazard classes: No information avaliable. 9.2.2. Other safety characteristics: No information avaliable SECTION 10. STABILITY AND REACTIVITY 10.1. Reactivity No hazardous reactions if stored and handled as prescribed/indicated. 10.2. Chemical stability The product is stable if stored and handled as prescribed/indicated. 10.3. Possibility of hazardous reactions No hazardous reactions if stored and handled as prescribed/indicated. 10.4. Conditions to Avoid Conditions to Avoid: Excessive heat, flame or other ignition sources. 10.5. Incompatible materials Avoid contact with strong acids and bases and oxidizing agents. ( 10.6. Hazardous decomposition products During combustion may form carbon monoxide and unidentified organic compounds. SECTION 11. TOXICOLOGICAL INFORMATION 11.1. Information on hazard classes as defined in Regulation (EC) No 1272/2008 Acute toxicity Based on the data available, the criteria for classification are not met. Skin corrosion/irritation Causes skin irritation. Serious eye damage/irritation Causes serious eye irritation. Respiratory or skin sensitisation May cause an allergic skin reaction. Germ cell mutagenicity Based on the data available, the criteria for classification are not met. Carcinogenicity Based on the data available, the criteria for classification are not met. Reproductive toxicity Based on the data available, the criteria for classification are not met. STOT-single exposure Based on the data available, the criteria for classification are not STOT-repeated exposure met. Based on the data available, the criteria for classification are Aspiration hazard not Based met. on the data available, the criteria for classification are not met. 11.2. Information on other hazards 11.2.1. Endocrine disrupting properties: Product not containing any component identified as having endocrine disrupting properties according to Regulation (EU) 2017 /2100. ( No information available 11.2.2. Other information: SECTION 12. ECOLOGICAL INFORMATION 12.1. Toxicity Assessment: Toxic to aquatic life with long lasting effects. Experimental/calculated data: • Toxicity for aquatic invertebrates: LCSO (48h): 14.5 mg/L. (OECDTG 202). • Toxicity for algae: ErCSO (72h): 30.4 mg/L. (OECDTG 201). 12.2. Persistence and degradability Biodegradation: > 67%. (OECD 301 D). The product is readily biodegradable 12.3. Bioaccumulative potential No information available. 12.4. Soil mobility No information available. 12.5. Results of PBT and vPvB assessment Product not containing any component that meets the criteria for PBT or vPvB according to Regulation (EC) 1907 /2006, Annex XIII. GERANIUM OIL, EGYPT Revision date: Print Date: 20-05-2024 07-03-2024 Version: 4.1/CLP/EN 12.6. Endocrine disrupting properties Product not containing any component identified as having endocrine disrupting properties according to Regulation (EU) 2017 /2100. 12.7. Other adverse effects See also sections 6, 7, 13 and 15 Do not allow to get into waste water or waterways. SECTION 13. DISPOSAL CONSIDERATIONS 13.1. Waste treatment methods Dispose of in accordance with national and local environmental regulations. ADR/RID/ADN IMDG IATA-ICAO 14.1. UN Number UN3082 14.2. UN Proper Shipping Name ENVIRONMENTALLY HAZARDOUS ENVIRONMENTALLY SUBSTANCE, LIQUID, N.O.S. HAZARDOUS SUBSTANCE, (GERANIUM) LIQUID, N.O.S. LIQUID, N.0.5. 14.3. Transport Hazard Class(es) 9 9 (GERANIUM) 14.4. Packing Group Ill 14.5. Environmental hazards Yes Additional information 14.6 Special precautions for user None known 14.7. Maritime transport in bulk according to IMO instruments No information available SECTION 15: REGULATORY INFORMATION 15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture No information available 15.2. Chemical safety assessment No chemical safety assessment has been carried out for the substance or mixture by the supplier Full text of the R-phrases, hazard statements and precautionary statements mentioned in section 3: H226 - Flammable liquid and vapour. H302 - Harmful if swallowed. H304 -May be fatal if swallowed and enters airways. H315 -Causes skin irritation. H317 -May cause an allergic skin reaction. H318 -Causes serious eye damage. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H361 - Suspected of damaging fertility or the unborn child. H400 -Very toxic to aquatic life. H410 -Very toxic to aquatic life with long lasting effects. H411 -Toxic to aquatic life with long lasting effects. H412- Harmful to aquatic life with long lasting effects. SPECIFICATION SHEET VERSION 3,00 VERSION DATE 19/09/22 PRINT DATE 30/01/23 PRODUCT GERANIUM OIL, EGYPT APPLICATIONS Industrial raw material not intended for direct use. IUPAC NAME GERANIUM OIL PLANT OF ORIGIN Pelargonium graveolens l'Her PART OF THE PLANT LEAVES AND STEMS SYNONYMS CAS 90082-51-2 CAS 2 8000-46-2 EINECS 290-140-0 FEMA 2508 TARIFF NUMBER 3301294900 REACH REGISTRATION NO. 01-2120769423-50 SPECIFICATIONS ASPECT AT 20°C CLEAR MOBILE LIQUID COLOUR YELLOW-BROWN ODOUR FRESH, SWEET, GREEN, HERBAL TASTE DENSITY AT 20°c (g / ml) 0,884 - 0,901 DENSITY 25/25 REFRACTIVE INDEX nD20 1,4600 - 1,4730 REFRACTIVE INDEX nD25 OPTICAL ROTATION (0} -14,00 I -6,00 BOILING POINT {°C} MEL TING POINT (0C) FLASH POINT (0C) 64,00 ASSAY(% GC) ACID VALUE (mg KOH/g} < 10 SOLUBILITY 1:4 IN ETHANOL 70° VAPOUR PRESSURE NOT DETERMINED OTHER SOLUBILITIES SOLUBLE IN ETHANOL OTHER TECHNICAL DATA ESTER VALUE: 31 TO 81 STABILITY AND STORAGE KEEP IN TIGHTLY CLOSED CONTAINER IN A COOL AND DRY PLACE, PROTECTED FROM LIGHT. WHEN STORED FOR MORE THAN 24 MONTHS, QUALITY SHOULD BE CHECKED BEFORE USE. WE BELIEVE THE ABOVE INFORMATION TO BE CORRECT BlJT WE DO NOT PRESENT IT AS ALL INCLUSIVE AND AS SUCH SHOULD BE USED AS A GUIDE. IT JS THE SOLE RESPONSIBILITY OF THE RECEIVER OF OUR PRODUCT TO COMPLY WITH EXISTING REGULATIONS AND INSTRUCTIONS. VEGAN CERTIFICATE 30 January 2023 Product: GERANIUM OIL, EGYPT This is to certify that, to the best of our knowledge, the above-mentioned material is suitable for the following diets: [Z] Vegan Does not contain any ingredient of animal origin (mammalian, poultry, fish. crustacean, mollusc) or animal derivatives (dairy, egg and bee products) including additives and